D&T Subcommittee Meeting Bil. 03/2020

posted Oct 1, 2020, 12:09 AM by Rafidah binti Abd Rahim   [ updated Oct 1, 2020, 12:31 AM ]

No.

Drug Name

Decision

1

Apixaban 2.5mg Film Coated Tablet (Eliquis)

Agreed to add Neurologist as prescriber.

2

Apixaban 2.5mg Film Coated Tablet (Eliquis)

Agreed to add Nephrologist as prescriber.

3

Apixaban 5mg Film Coated Tablet (Eliquis)

Agreed to add Neurologist as prescriber.

4

Apixaban 5mg Film Coated Tablet (Eliquis)

Agreed to add Nephrologist as prescriber.

5

Bevacizumab 100mg Injection (MVASI)

Rejected as Special Formulary.

6

Bevacizumab 400mg Injection (MVASI)

Agreed to defer to next D&T meeting.
To get input from Ophthalmology team regarding MVASI use in the treatment of Age-related Macular Degeneration (AMD).

7

Daptomycin 500mg Injection (Cubicin)

Agreed to accept as Standard Formulary.
Limited to 8 patients per year.
Agreed to remove Tigecycline from the UMMC Formulary.

8

Desmopressin 4mcg Injection (Minirin)

Agreed to add Intensive Care Team as prescriber.

9

Dulaglutide 0.75mg Injection
(Trulicity)

Rejected as Special Formulary.

Dulaglutide 1.5mg available in Special Formulary.

10

Dulaglutide 1.5mg Injection
(Trulicity)

Agreed to add Cardiologist & Nephrologist (for patients with eGFR 15-30 only) as prescriber.

11

Erythromycin 500mg Injection

Agreed to accept as Standard Formulary.

12

Evolocumab 140mg Injection (Repatha)

Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

13

Guselkumab 100mg Injection (Tremfya)

Agreed to accept as Special Formulary.

14

Rivaroxaban 2.5mg Tablet (Xarelto)

Rejected to add in new strength with new indication and new prescriber.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

15

Trastuzumab 600mg/5mL Inj (Herceptin SC)

Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

16

Ustekinumab 130mg/26mL Injection (Stelara)



Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

17

Ustekinumab 90mg/1.0mL Injection (Stelara)

Rejected as Special Formulary.

Suggest to apply for use via Borang Ubat Khas (BUK) on a named patient basis.

18

Iron Hydroxide Sucrose Complex 100mg/5mL Injection
(Venofer)

Agreed to remove Venofer from the UMMC Formulary.

Agreed to accept Monofer as Special Formulary.

19

Oxymetholone 50mg Tablet

Agreed to remove Oxymetholone 50mg tablet from the UMMC Formulary.

20

Sodium chloride 0.9% Eye Drops

Agreed to remove Sodium Chloride 0.9% Eye Drops from the UMMC Formulary.

21

Tigecycline 50mg Injection (Tygacil)

Agreed to remove Tigecycline from the UMMC Formulary.
Agreed to accept Daptomycin as Standard Formulary.

22

Deferasirox 125mg Dispersible Tablet
(EXJADE)
Rejected from procurement discontinuation.
EXJADE continues as Special Formulary. Pharmacy to monitor stock movement closely to prevent wastage due to expired stock.

23

Iron (III) Isomaltoside 500mg/5mL Injection
(Monofer)

Agreed to accept as Special Formulary.
Agreed to delete Venofer from the UMMC Formulary.


Disclaimer: 

For new drug requests, physical stock availability will depend on procurement processes. 

Tender items will take about 3-6 months, non tender items will take about 1-3 months. 

Online formulary will be updated once physical stock is available or has depleted in UMMC Pharmacy.